Multiple sclerosis (MS) is treated on two fronts: slowing the disease itself with long-term medications, and managing the day-to-day symptoms like fatigue, stiffness, and pain. Most people with relapsing MS who start treatment early can significantly reduce flare-ups and delay disability progression. The right combination of therapies depends on how active your disease is, your tolerance for risk, and what symptoms affect your quality of life most.
Disease-Modifying Therapies
Disease-modifying therapies (DMTs) are the backbone of MS treatment. They don’t cure the disease, but they reduce the frequency of relapses and slow the formation of new brain lesions. There are now more than a dozen approved options, ranging from self-injections and daily pills to infusions given a few times a year. European and American guidelines strongly recommend starting a DMT early in anyone with active relapsing-remitting MS, meaning you’ve had clinical relapses or new lesions on MRI.
The choice of which DMT to use depends on several factors: how aggressive your MS appears, other health conditions you have, the drug’s safety profile, and practical considerations like whether you prefer a pill at home or an infusion at a clinic. Older injectable therapies like interferons and glatiramer acetate are modest in their effectiveness but have decades of safety data. Newer oral and infusion therapies tend to be more potent. If you start on a milder therapy and your disease remains active, guidelines strongly recommend switching to something more effective rather than staying the course.
How High-Efficacy Infusions Work
Some of the most effective MS treatments are infusions that target a protein called CD20, found on the surface of certain immune cells (B cells) that drive inflammation in MS. By depleting these cells, the drugs dramatically reduce relapses and new lesion activity. Three CD20-targeting therapies are widely used, and they differ mainly in how they’re given.
Ocrelizumab is delivered as an intravenous infusion every six months at an infusion center. Ofatumumab is a monthly injection you give yourself at home with a prefilled pen, which makes it more convenient for people who want to avoid clinic visits. Ublituximab is another intravenous infusion, given on a similar six-month schedule after an initial loading period. All three are considered high-efficacy options and are often used when the disease is active or when milder therapies haven’t worked well enough.
Oral Medications
Several pills are approved for relapsing MS. One important category works by trapping certain immune cells in your lymph nodes so they can’t reach your brain and spinal cord. These drugs require some monitoring when you first start: you’ll need a heart rhythm check (ECG) before beginning, and some people need cardiac monitoring during their first dose because the medication can temporarily slow heart rate. An eye exam is also recommended before or shortly after starting, since there’s a small risk of swelling in the back of the eye, particularly if you have diabetes or a history of eye inflammation.
Other oral options work through different mechanisms, including reducing the number of circulating immune cells or interfering with how they multiply. Your neurologist will walk you through the monitoring requirements for each, which can include regular blood work to check liver function and immune cell counts.
Treating Relapses
When a flare-up hits, the standard treatment is a short course of high-dose corticosteroids, typically given intravenously over three to five days. This doesn’t change the long-term course of MS, but it shortens the duration and severity of the relapse by quickly tamping down inflammation. Most people receive this at an infusion center, though some neurologists arrange home infusions. You may feel jittery, have trouble sleeping, or notice mood changes during the course, but these effects are temporary.
Managing Fatigue
Fatigue is one of the most common and disabling MS symptoms, affecting the majority of people with the disease. No medication is specifically approved for MS fatigue, but several are prescribed off-label. Amantadine, typically taken at 100 mg twice daily, is one of the most commonly tried options. Modafinil, a wakefulness-promoting drug, is another, also usually dosed at up to 200 mg per day. Stimulant medications similar to those used for ADHD are sometimes tried as well, starting at low doses and gradually increasing.
None of these medications work dramatically for everyone, and finding the right one often involves some trial and error. Non-drug strategies matter just as much: structured rest periods, energy conservation techniques (like planning demanding tasks for your best time of day), and regular exercise all contribute to managing fatigue over time.
Treating Spasticity and Stiffness
Muscle stiffness and spasms are common, especially in the legs. Baclofen is considered the first-line medication and works by calming overactive nerve signals in the spinal cord. Tizanidine is another option, though its effects wear off quickly, requiring doses every six to eight hours. Gabapentin is sometimes added alongside these as a supporting treatment.
When pills alone aren’t enough, there are targeted options. Botulinum toxin injections can relax specific muscles for three to four months at a time, which is helpful when stiffness is concentrated in certain areas. For severe, widespread spasticity that doesn’t respond to oral medications, a surgically implanted pump can deliver baclofen directly to the fluid around the spinal cord, using much smaller doses than what’s needed by mouth and causing fewer side effects like drowsiness.
Exercise and Rehabilitation
Exercise is one of the most consistently beneficial things you can do for MS, improving strength, balance, mobility, fatigue, and overall quality of life. Guidelines recommend two to three days per week of moderate aerobic exercise (like walking, cycling, or swimming) for 10 to 30 minutes per session, plus two to three days per week of resistance training. Start at the lower end and build up gradually over weeks.
For resistance training, aim for one to three sets of 8 to 15 repetitions per exercise, focusing on major muscle groups, especially the legs and whichever muscles are weakest. If you’re at risk for falls, seated exercises like a recumbent bike or weight machines are safer, ideally with supervision from a physical therapist who understands MS. The goal isn’t to push to exhaustion. Moderate intensity, roughly a level where you can talk but feel you’re working, is the sweet spot.
Vitamin D and Nutrition
Low vitamin D levels are linked to higher MS disease activity, and most neurologists check your blood levels and recommend supplementation if you’re low. The Endocrine Society considers blood levels of 30 ng/mL sufficient and 40 to 60 ng/mL ideal. Most adults need 1,500 to 2,000 IU of vitamin D daily to reach and maintain levels above 30 ng/mL, which is well within the safe range (the upper limit is considered 10,000 IU per day).
Correcting a deficiency won’t replace a DMT, but it’s a low-risk addition to your overall treatment plan. Beyond vitamin D, no specific diet has been proven to alter the course of MS, though a generally healthy eating pattern rich in fruits, vegetables, whole grains, and omega-3 fatty acids supports overall health and may help with energy and inflammation.
The Shift Toward Early Aggressive Treatment
For years, the standard approach was to start with milder therapies and escalate only if the disease broke through. That thinking is shifting. Growing evidence suggests that starting with a high-efficacy therapy early, before significant damage accumulates, leads to better long-term outcomes. This is sometimes called the “hit hard, hit early” philosophy.
The decision still depends on individual circumstances. A person with a single mild relapse and few MRI lesions may reasonably start with a moderate therapy, while someone with frequent relapses, many lesions, or signs of early disability progression may benefit from jumping straight to a high-efficacy option. The most important thing is that treatment starts promptly and is reassessed regularly, with a clear plan to escalate if the current therapy isn’t controlling the disease.